top of page
Desert Dune

VRCT

Completed

STUDY OVERVIEW

SUMMARY

We conducted a randomized controlled trial (2019–2020) with 69 inpatients living with dementia in an acute care hospital, the largest VR study in this population and setting at the time. Participants were assigned to VR or standard care. The VR group viewed 360° films every 1–3 days. We measured behavioural symptoms (including aggression), falls, length of stay, and quality of life, alongside observational and interview data to understand participant experience feasibility.


Clinical Trials ID: NCT03941119

KEY FINDINGS

VR significantly reduced aggressive behaviours and was safe and enjoyable. No clear effects were seen for other outcomes, but the study provided insight into feasibility, engagement, and participant preferences. Short sessions (~7 minutes) and variable participation (average 1.6 sessions) highlight challenges of delivering VR in acute care and the need to focus on realistic outcomes and more sensitive measures. Observational findings informed the next iteration, including culturally relevant content, nature, animals, and music.

PUBLICATIONS

PARTNERS

FUNDERS

PrescribingVR logo

LOCATION

489 College Street, Suite 400
Toronto, Ontario, M6G 1A5

NAVIGATION

© 2026 by PrescribingVR

CONNECT WITH US

bottom of page